115 related articles for article (PubMed ID: 8784300)
1. Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
Smith KJ; Vidmar D; Skelton HG; Hackley BE
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):491-3. PubMed ID: 8784300
[No Abstract] [Full Text] [Related]
2. The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma.
Vonderheid EC; Ekbote SK; Kerrigan K; Kalmanson JD; Van Scott EJ; Rook AH; Abrams JT
J Invest Dermatol; 1998 Jun; 110(6):946-50. PubMed ID: 9620303
[TBL] [Abstract][Full Text] [Related]
3. Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
Stricker RB; Goldberg B; Mills LB; Epstein WL
J Am Acad Dermatol; 1995 Oct; 33(4):608-11. PubMed ID: 7673493
[TBL] [Abstract][Full Text] [Related]
4. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.
Smith KJ; Skelton HG; Nelson A; Wagner KF; Hackley BE
Dermatology; 1997; 195(2):145-9. PubMed ID: 9310722
[TBL] [Abstract][Full Text] [Related]
5. Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil.
Traub A; Margulis SB; Stricker RB
Dermatology; 1997; 195(4):369-73. PubMed ID: 9529559
[TBL] [Abstract][Full Text] [Related]
6. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
[No Abstract] [Full Text] [Related]
7. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
[TBL] [Abstract][Full Text] [Related]
8. The failure of immunotherapy with dinitrochlorobenzene and Rhus extract for recurrent conjunctival squamous papillomas.
Novick NL; Bosniak SL
J Dermatol Surg Oncol; 1986 Jun; 12(6):602-5. PubMed ID: 2940277
[TBL] [Abstract][Full Text] [Related]
9. Topical immunotherapy with contact sensitizers for viral warts.
Gibbs S
Br J Dermatol; 2002 Apr; 146(4):705. PubMed ID: 11966711
[No Abstract] [Full Text] [Related]
10. Nickel systemic contact dermatitis.
Verna N; Di Claudio F; Balatsinou L; Schiavone C; Caruso R; Renzetti A; Gabriele E; Turi MC; Feliziani A; Di Gioacchino M
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):11-4. PubMed ID: 17761099
[No Abstract] [Full Text] [Related]
11. Improvement of lichen nitidus after topical dinitrochlorobenzene application.
Kano Y; Otake Y; Shiohara T
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):305-8. PubMed ID: 9703140
[TBL] [Abstract][Full Text] [Related]
12. Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis.
Ishizaki K; Yamada A; Yoh K; Nakano T; Shimohata H; Maeda A; Fujioka Y; Morito N; Kawachi Y; Shibuya K; Otsuka F; Shibuya A; Takahashi S
J Immunol; 2007 Jan; 178(1):605-12. PubMed ID: 17182601
[TBL] [Abstract][Full Text] [Related]
13. Persistent warts in an adolescent with severe atopy.
Monroe JR
JAAPA; 2006 Jul; 19(7):50. PubMed ID: 16869153
[No Abstract] [Full Text] [Related]
14. Contact sensitizer 2,4-dinitrochlorobenzene is a highly potent human TRPA1 agonist.
Saarnilehto M; Chapman H; Savinko T; Lindstedt K; Lauerma AI; Koivisto A
Allergy; 2014 Oct; 69(10):1424-7. PubMed ID: 25041656
[TBL] [Abstract][Full Text] [Related]
15. Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: systemic immunotherapy.
Yoshizawa Y; Matsui H; Izaki S; Kitamura K; Maibach HI
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):258-62. PubMed ID: 10642682
[TBL] [Abstract][Full Text] [Related]
16. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
Djawari D; Körner E; Haneke E
Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
[TBL] [Abstract][Full Text] [Related]
17. [2,4-dinitrochlorobenzene (DNCB) in the study of delayed hypersensitivity in some infectious diseases].
Cirelli A; D'Amato C; Lanzalone CM
Boll Soc Ital Biol Sper; 1974 Aug; 50(15):1157-62. PubMed ID: 4549182
[No Abstract] [Full Text] [Related]
18. Inducing viral immunity without a vaccine--possible use with human immunodeficiency virus.
Stone OJ
Med Hypotheses; 1993 Feb; 40(2):95-6. PubMed ID: 8455482
[TBL] [Abstract][Full Text] [Related]
19. Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.
Mayorga C; Blazquez AB; Doña I; Gomez F; Chaves P; Sanchez-Quintero MJ; Blanca-López N; Melendez L; Blanca M; Torres MJ
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):47-51. PubMed ID: 22727157
[TBL] [Abstract][Full Text] [Related]
20. Transfer factor therapy in immunodeficiency.
Griscelli C
Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
